Safety and efficacy of 24 weeks of pemvidutide in metabolic dysfunction-associated steatotic liver disease: A randomized, controlled clinical trial.

Rezdiffra (resmetirom) - Madrigal Pharma

efruxifermin (AKR-001) - Akero Therap

pemvidutide (ALT-801) - Altimmune

http://www.ncbi.nlm.nih.gov/pubmed/41113119

Bertrand Georges; Jay Yang; John J Suschak; Julio A Gutierrez; M Scot Roberts; M Scott Harris; Sarah K Browne; Shaheen Tomah

Oct 20, 2025